Ann Arbor, MI, United States of America

Yong Li

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yong Li - Innovator in Pharmaceutical Modulation

Introduction

Yong Li is a prominent inventor based in Ann Arbor, MI (US), known for his contributions to pharmaceutical innovations. He holds two patents that focus on the modulation of the C5a receptor, which plays a significant role in various diseases.

Latest Patents

Yong Li's latest patents include "Fused piperidinyl bicyclic and related compounds as modulators of C5a receptor." This invention relates to compounds that modulate the activities of the mammalian C5a receptor by directly binding to it. The patent also covers pharmaceutical compositions containing these compounds and their applications in treating diseases or disorders associated with pathogenic activation of C5a receptors.

Career Highlights

Yong Li is currently associated with Inflarx GmbH, where he continues to advance his research and development efforts in the pharmaceutical field. His work is pivotal in creating innovative solutions for health challenges.

Collaborations

Yong Li collaborates with notable colleagues, including Renfeng Guo and Niels Christoph Riedemann, contributing to a dynamic research environment that fosters innovation.

Conclusion

Yong Li's work in modulating the C5a receptor through innovative compounds showcases his significant impact on pharmaceutical research. His contributions are vital for the development of new treatments for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…